THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,248 | -16.6% | 59,009 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $610,743 | -4.6% | 59,009 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $640,248 | -3.3% | 59,009 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $662,081 | +10.7% | 59,009 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $598,000 | +11.8% | 59,009 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $535,000 | -5.1% | 59,009 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $564,000 | -13.5% | 59,009 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $652,000 | +49.2% | 59,009 | 0.0% | 0.01% | +66.7% |
| Q3 2021 | $437,000 | -49.0% | 59,009 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $857,000 | -28.8% | 59,009 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $1,204,000 | +14.8% | 59,009 | 0.0% | 0.01% | -11.1% |
| Q4 2020 | $1,049,000 | -23.9% | 59,009 | -36.8% | 0.01% | -40.0% |
| Q3 2020 | $1,379,000 | -29.6% | 93,300 | 0.0% | 0.02% | -31.8% |
| Q2 2020 | $1,958,000 | -9.2% | 93,300 | 0.0% | 0.02% | -24.1% |
| Q1 2020 | $2,156,000 | -10.8% | 93,300 | 0.0% | 0.03% | +31.8% |
| Q4 2019 | $2,416,000 | +33.0% | 93,300 | 0.0% | 0.02% | +29.4% |
| Q3 2019 | $1,817,000 | +19.2% | 93,300 | 0.0% | 0.02% | +21.4% |
| Q2 2019 | $1,524,000 | -27.9% | 93,300 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $2,115,000 | -11.4% | 93,300 | 0.0% | 0.02% | -14.3% |
| Q4 2018 | $2,388,000 | -21.7% | 93,300 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $3,048,000 | +44.0% | 93,300 | 0.0% | 0.02% | +40.0% |
| Q2 2018 | $2,116,000 | -6.5% | 93,300 | 0.0% | 0.02% | -6.2% |
| Q1 2018 | $2,263,000 | -13.0% | 93,300 | 0.0% | 0.02% | -5.9% |
| Q4 2017 | $2,602,000 | -18.6% | 93,300 | 0.0% | 0.02% | -19.0% |
| Q3 2017 | $3,195,000 | -14.0% | 93,300 | 0.0% | 0.02% | -16.0% |
| Q2 2017 | $3,717,000 | -2.3% | 93,300 | -9.7% | 0.02% | 0.0% |
| Q1 2017 | $3,804,000 | +15.5% | 103,300 | 0.0% | 0.02% | +19.0% |
| Q4 2016 | $3,293,000 | -23.5% | 103,300 | -13.0% | 0.02% | -25.0% |
| Q3 2016 | $4,305,000 | -28.6% | 118,800 | -55.3% | 0.03% | -30.0% |
| Q2 2016 | $6,029,000 | -11.6% | 265,700 | -26.7% | 0.04% | -7.0% |
| Q1 2016 | $6,819,000 | +1.8% | 362,700 | -11.2% | 0.04% | +7.5% |
| Q4 2015 | $6,697,000 | +18.6% | 408,600 | -20.5% | 0.04% | +33.3% |
| Q3 2015 | $5,646,000 | -10.9% | 513,700 | +5.5% | 0.03% | +11.1% |
| Q2 2015 | $6,337,000 | -27.8% | 486,700 | -3.8% | 0.03% | -18.2% |
| Q1 2015 | $8,777,000 | +2.4% | 505,900 | -11.9% | 0.03% | +10.0% |
| Q4 2014 | $8,570,000 | +291.3% | 574,400 | +504.6% | 0.03% | +328.6% |
| Q3 2014 | $2,190,000 | -32.1% | 95,000 | -6.2% | 0.01% | -30.0% |
| Q2 2014 | $3,227,000 | – | 101,228 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |